At Psivant Therapeutics we have assembled a diverse team with extensive experience across disciplines ranging from physics and computer-aided drug design to chemistry and structural biology. This continuum of complementary experience is essential for driving our scientific vision and bringing innovative therapeutics to patients in need.
Psivanteers
-
Alex Liholips
Senior Software Engineer
-
Ana Silveira, Ph.D.
Molecular Simulations Lead
-
Chrissy Bracken
Immunology Lead, Principal Scientist
-
David Cerutti, Ph.D.
Scientific Engineering Fellow
-
Derek MacPherson, Ph.D.
Biophysics and Structural Biology Lead
-
Dinal Patel
Senior Associate Scientist
-
Evan Chiswick, Ph.D.
Immunology Lead, Scientific Director
-
Finith Jernigan, Ph.D.
Head of Early Discovery
-
Kevin Huynh
Senior Research Associate
-
Lynn Grice
Executive Assistant
-
Rafal Wiewiora, Ph.D.
Molecular Design Lead
-
Shivam Patel, M.S.
Data Science Lead
-
Thomas Schultz
Associate Director, Engineering
-
Todd Soltwedel, M.S.
Research Chemist
-
Trevor Dennis
Senior DevOps Engineer
-
Vishal Sindhava, Ph.D.
Immunology Lead, Scientific Director
Board of Directors
-
Srini Akkaraju, M.D., Ph.D.
Founder and Managing General Partner, Samsara Biocapital
-
Christina Isacson, Ph.D.
Partner, Lightstone Ventures
-
Alex Gasner
EVP, Roivant Health
-
James P. Edwards, Ph.D.
Chief Executive Officer, Psivant Therapeutics; Venture Partner, Samsara Biocapital
-
Woody Sherman, Ph.D.
Founder and Chief Innovation Officer, Psivant Therapeutics
-
Erik Venker, M.D., Pharm.D.
President and Chief Operating Officer, Roivant Sciences